The global pharmaceutical manufacturing equipment market size is projected to grow from USD 19.41 billion in 2024 to USD 26.94 billion in 2029, recording a CAGR of 6.8% during the forecast period. Rising demand for generic drugs is driving the growth of the pharmaceutical manufacturing equipment market. Whereas the demand for refurbished equipments is restraining the growth of the pharmaceutical manufacturing equipment market.
“Packaging machines segment is expected to witness highest CAGR during the forecasted period in pharmaceutical manufacturing equipment market.”
The packaging machines segment is expected to have the highest CAGR in the pharmaceutical manufacturing equipment market due to a few critical factors. Innovative drug delivery formats such as pre-filled syringes, single-dose vials, and blister packs are gaining much importance in the pharmaceutical industry, which requires advanced and sophisticated packaging solutions. In addition, adoption of sophisticated packaging technologies, such as serialization and tamper-evident solutions, is stringent regulatory requirements for drug safety and traceability. It is also due to the growing trend of patient-centric healthcare, where packaging is playing an important role in enhancing user convenience and compliance. The growth in biologics, personalized medicines, and vaccines also requires highly precise and sterile packaging environments, thereby further driving demand for advanced packaging machines.
"Liquid segment is likely to witness highest CAGR in pharmaceutical manufacturing equipment market during forecasted period .”
The liquid segment is witnessing the CAGR due to regulatory emphasis on pediatric formulations. Regulatory bodies such as the US Food and Drug Administration (FDA) have stressed the need for age-appropriate liquid medications to address the challenges children face with swallowing solid forms like tablets and capsules. This push ensures better compliance, safety, and efficacy in pediatric treatments, significantly driving demand for liquid dosage forms. Additionally, liquid medications allow precise dosing, making them ideal for children and other patients requiring tailored administration. The growing focus on pediatric health has led pharmaceutical companies to innovate in liquid formulations, opening new market opportunities.
“Europe is expected to hold the second largest market share of the pharmaceutical manufacturing equipment market during forecasted period”.
The region is marked by a very competitive landscape, dominated by both large pharmaceutical companies and SMEs, thus facilitating innovation and diversification in terms of products. A tremendous investment in R&D for new manufacturing technologies supports the region’s dominance in this market. Biopharmaceuticals form a great shift in the industry and have transformed it across Europe; Germany has emerged to be the largest producer of EU-approved biopharmaceutical substances. This growth is matched by increasing revenues from biologics, which further strengthens the the pharmaceutical manufacturing equipment market in Europe.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Company Type - Tier 1 – 40%, Tier 2 – 35%, Tier 3 – 25%
• By Designation? C-level Executives - 45%, Directors - 35%, Others - 20%
• By Region?North America - 30%, Europe - 25%, Asia Pacific - 40%, RoW - 5%
The pharmaceutical manufacturing equipment market is dominated by a few globally established players such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India), K?rber AG (Germany), Thermo Fisher Scientific Inc. (US), Marchesini Group (Italy), MG2 s.r.l (Italy), Glatt GmbH (Germany). The study includes an in-depth competitive analysis of these key players in the pharmaceutical manufacturing equipment market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The report segments the pharmaceutical manufacturing equipment and forecasts its size by equipment type, end product type, and region. The report also discusses the drivers, restraints, opportunities, and challenges pertaining to the market. It gives a detailed view of the market across four main regions?North America, Europe, Asia Pacific, and RoW. Supply chain analysis has been included in the report, along with the key players and their competitive analysis in the pharmaceutical manufacturing equipment ecosystem.
Key Benefits to Buy the Report:
• Analysis of key drivers (Rising demand for pharmaceuticals, technological advancements in equipment and growing implementation & adoption of regulatory guidelines). Restraint (Demand for refurbished equipment), Opportunity (Growth in personalized medicines), Challenges (Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment).
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pharmaceutical manufacturing equipment market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical manufacturing equipment market across varied regions
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India) among others in the pharmaceutical manufacturing equipment market.